WHO ARE WE

dfdsf Biotech is a global leading research and product development platform for precision oncology of malignant tumors.dfdsf Biotech is a global leading research and product development platform for precision oncology of malignant tumors.dfdsf Biotech is a global leading research and product development platform for precision oncology of malignant tumors.

Kante Biotech is a global leading research and product development platform for precision oncology of malignant tumors. Committed to the vision of building a global anti-cancer life community, the company focuses on developing innovative precision oncology technologies and full-cycle products for malignant tumors, empowering cancer diagnosis and treatment with innovative technology, and striving for human health. Specializing in gastrointestinal tumors such as pancreatic, liver, and esophageal cancers, as well as gonadal tumors like ovarian, breast, and prostate cancers, our products cover different application scenarios including early screening and diagnosis, companion diagnosis, and prognostic monitoring for characteristic tumors and pan-cancers.

The company’s independently developed world’s first serum microRNA-based multi-target early diagnosis kit for pancreatic cancer have obtained Chinese invention patents and NMPA Class III in vitro diagnostic reagent registration certificates, and have established close collaborations with multiple national authoritative tertiary hospitals and precision medicine centers.